Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille R Simoneau

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature|May 18, 2022
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.
Cell|May 15, 2021
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variantXianding Deng, Miguel A Garcia-Knight, Mir M Khalid, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutationXianding Deng, Miguel A Garcia-Knight, Mir M Khalid, et al.
Science (New York, N.Y.)|November 6, 2020
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive SpikeMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformationMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Science (New York, N.Y.)|October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsDavid E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature|May 18, 2022
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.
Cell|May 15, 2021
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variantXianding Deng, Miguel A Garcia-Knight, Mir M Khalid, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutationXianding Deng, Miguel A Garcia-Knight, Mir M Khalid, et al.
Science (New York, N.Y.)|November 6, 2020
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive SpikeMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformationMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Science (New York, N.Y.)|October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsDavid E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Pageof 3